Le Lézard
Classified in: Health, Business, Covid-19 virus
Subject: AVO

Top Tennessee Employers Warned To Avoid BCBST Policy


SCHAUMBURG, Ill., June 18, 2020 /PRNewswire/ -- Continuing with its campaign to alert of dangerous changes to BlueCross BlueShield of Tennessee (BCBST) prescription policies, the Coalition of State Rheumatology Organizations (CSRO) today alerted leaders of many of the largest employers in Tennessee. In addition to communications sent previously to the Tennessee Chamber of Commerce and leaders of BCBST, physician and patient advocates are warning the business community of a looming threat to the Tennessee workforce and the state economy.

The BCBST policy (scheduled to begin on July 1) forces patients to utilize its preferred specialty pharmacies for infusion therapies making it nearly impossible for treatments to be conducted in physician offices ? under their care.

"A letter sent to Tennessee employers, some of which are likely BCBST customers, states in part:

We hope that you will alert your human resources and benefits administrators to the dangers associated with the BCBST plan. I urge you (and your benefits team) to familiarize yourself with the facts ? as BCBST has been less than accurate in their defense of its dangerous policies. It has even blamed you, its customers, as a reason for its implementation ? stating that its customers have demanded the cost savings measures.

Negative impacts on your employees will be much worse (and expensive) than any savings promised by BCBST.

"Employers in Tennessee are already hurting from the impacts of COVID-19," explained Dr. Madeline Feldman, CSRO President. High risk COVID-19 patients who are chronically ill run the risk of losing access to treatments at their doctor's office if the BCBST policy is implemented.

Tennessee leaders receiving the letters include:

"As physicians on the front lines of medical care we will always fight for our patients ? just as we hope these business leaders fight for their employees," Dr. Feldman continued.

The CSRO is comprised of professional rheumatology societies formed to advocate for excellence in rheumatologic disease care and ensuring access to the highest quality care

CONTACT
Dan Rene of kglobal
202-329-8357 or [email protected]

SOURCE Coalition of State Rheumatology Organizations


These press releases may also interest you

at 01:21
Aker Solutions has delivered strong revenue growth and improved profitability in the first quarter of 2024 compared to the same period last year. With a solid backlog and high tendering activity, the company is well positioned for future profitable...

at 01:18
First Quarter Highlights            HMH delivered an EBITDA (adj.) of USD 33 million in quarter, about 75% increase year-over-year driven by higher aftermarket activityNES Fircroft delivered 17% increase in EBITDA and 12% revenue growth...

at 01:17
Quarter 1, 2024 - High profitability and strong cash flow Net sales decreased 4.1% to SEK 34,850m (36,352)Organic growth amounted to -4.0%, of which volume accounted for -1.8% and price/mix -2.2%. Excluding restructuring and exited contracts, volumes...

at 01:16
PERIOD 1 JANUARY - 31 MARCH 2024 Net sales decreased by 7% (same in local currencies) and amounted to SEK 1,995.2 (2,135.5) million. Acquired business contributed 1%.Operating result amounted to SEK 185.5 (313.5) million.Result for the period...

at 01:05
Teck Resources Limited (Teck) today announced its unaudited first quarter results for 2024. "All outstanding major construction at our QB operation was completed in the first quarter, including the shiploader and molybdenum plant, and we marked the...

at 00:50
OKX, a leading Web3 technology company, has issued updates for April 25, 2024. OKX Wallet Now Integrated with XION, a User-First ...



News published on and distributed by: